Landscapes / Targets
4-1BB
23 drugs act on 4-1BB, in 45 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs23
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 24 Dec 2026Phase 2 trial completes | |||
| Next date | 24 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumour, Advanced Solid Tumor and 6 more | ||||
| Open drug page | |||||
PD-L1/4-1BB bispecific antibody |
Phase 3 | 30 Jul 2027Phase 3 trial completes | |||
| Next date | 30 Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC | ||||
| Open drug page | |||||
— |
Roche · Public ROG.SW |
Phase 1/2 | 28 Dec 2026Phase 1/2 trial completes | ||
| Next date | 28 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Lymphoma, Non-Hodgkin | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC) and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Hematologic Malignancies, Breast Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia and 9 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Aug 2027Phase 1 trial completes | |||
| Next date | Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC) and 4 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Aug 2027Phase 1/2 trial completes | |||
| Next date | 31 Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 2 | 31 Oct 2027Phase 2 trial completes | |||
| Next date | 31 Oct 2027 · Phase 2 trial completes | ||||
| Also tested for | Head and Neck Squamous Cell Carcinoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | 2 Dec 2027Phase 1/2 trial completes | |||
| Next date | 2 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 2 | Sep 2028Phase 2 trial completes | |||
| Next date | Sep 2028 · Phase 2 trial completes | ||||
| Also tested for | Neuroendocrine Neoplasm, Neuroendocrine Carcinomas and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2029Phase 1/2 trial completes | |||
| Next date | 31 Dec 2029 · Phase 1/2 trial completes | ||||
| Also tested for | MTD | ||||
| Open drug page | |||||
— |
Regeneron · Public REGN |
Phase 1/2 | 27 Oct 2030Phase 1/2 trial completes | ||
| Next date | 27 Oct 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC) | ||||
| Open drug page | |||||
— |
BioNTech · Public BNTX |
Phase 1/2 | Dec 2030Phase 1/2 trial completes | ||
| Next date | Dec 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumor, Metastatic Colorectal Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | HER2-positive Gastric Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Locally Advanced/Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Advanced Malignant Neoplasm | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Recurrent Glioma, Solid Tumor | ||||
| Open drug page | |||||
— |
Hanmi · Public 128940.KS |
Phase 1 | Aug 2027Phase 1 trial completes | ||
| Next date | Aug 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced or Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Oct 2027Phase 1 trial completes | |||
| Next date | 30 Oct 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Cancer, Metastatic Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 23 of 23 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026